SMTL ID : 6qtg.1

Crystal structure of human CDK8/CYCC in complex with BI-1347

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

hetero-1-1-mer

Ligands

1 x JH8: 2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-~{N},~{N}-dimethyl-ethanamide(Non-covalent)

JH8.1: 15 residues within 4Å: Chain A: V.29, G.30, R.31, V.37, A.52, I.81, F.99, D.100, Y.101, A.102, D.105, H.108, A.157, L.160, R.358 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.37, A:V.37, A:A.52, A:I.81, A:F.99, A:L.160, A:L.160 Hydrogen bonds: A:R.31, A:A.102 pi-Stacking: A:H.108 pi-Cation interactions: A:R.358

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hofmann, M.H. et al., Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance. Mol.Cancer Ther. (2020)

Release Date

2020-03-18

Peptides

Cyclin-dependent kinase 8: A
Cyclin-C: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 8

Cyclin-C

Related Entries With Identical Sequence